|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 May 2002, Vol. 99, No. 10, pp. 3668-3675
IMMUNOBIOLOGY
Changes in T-cell receptor VB repertoire in aplastic anemia:
effects of different immunosuppressive regimens
Hoon Kook,
Antonio M. Risitano,
Weihua Zeng,
Marcin Wlodarski,
Craig Lottemann,
Ryotaro Nakamura,
John Barrett,
Neal S. Young, and
Jaroslaw P. Maciejewski
From the Hematology Branch of the National Heart, Lung,
and Blood Institute, National Institutes of Health, Bethesda, MD.
We studied the degree and the pattern of skewing of the variable
region of -chain (VB) T-cell receptor (TCR) repertoire in aplastic anemia (AA) at initial presentation and after
immunosuppression using a high-resolution analysis of the TCR VB
complementarity-determining region 3 (CDR3). Age-matched healthy
individuals and multitransfused patients with non-immune-mediated
hematologic diseases were used as controls. In newly diagnosed AA, the
average frequency of CDR3 size distribution deviation indicative of
oligoclonal T-cell proliferation was increased (44% ± 33% vs 9% ± 9%; P = .0001); AA patients with human leukocyte antigen
(HLA)-DR2 and those with expanded paroxysmal nocturnal hemoglobinuria
clones showed more skewed VB repertoires. Nonrandom oligoclonal
patterns were found for VB6, VB14-16, VB21, VB23, and VB24 subfamilies
in more than 50%, and for VB15, VB21, and VB24 in more than 70% of AA
patients with HLA-DR2. Patients received immunosuppression with
antithymocyte globulin (ATG)/cyclosporine (CsA) or cyclophosphamide
(CTX) with CsA in combination, and their VB repertoire was reanalyzed
after treatment. Whereas no significant change in the degree of VB
skewing in patients who had received ATG was seen, patients treated
with CTX showed a much higher extent of oligoclonality within all VB
families, consistent with a profound and long-lasting contraction of
the T-cell repertoire. VB analysis did not correlate with the
lymphocyte count prior to lymphocytotoxic therapy; however, after
therapy the degree of VB skewing was highly reflective of the decrease
in lymphocyte numbers, suggesting iatrogenic gaps in the VB repertoire
rather than the emergence of clonal dominance. Our data indicate that
multiple specific clones mediate the immune process in AA.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. W. Wlodarski, L. P. Gondek, Z. P. Nearman, M. Plasilova, M. Kalaycio, E. D. Hsi, and J. P. Maciejewski
Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome
Blood,
October 15, 2006;
108(8):
2632 - 2641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Wlodarski, C. O'Keefe, E. C. Howe, A. M. Risitano, A. Rodriguez, I. Warshawsky, T. P. Loughran Jr, and J. P. Maciejewski
Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia
Blood,
October 15, 2005;
106(8):
2769 - 2780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sloand, L. Mainwaring, M. Fuhrer, S. Ramkissoon, A. M. Risitano, K. Keyvanafar, J. Lu, A. Basu, A. J. Barrett, and N. S. Young
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
Blood,
August 1, 2005;
106(3):
841 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cattaneo
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2004;
24(11):
1980 - 1987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lu, A. Basu, J. J. Melenhorst, N. S. Young, and K. E. Brown
Analysis of T-cell repertoire in hepatitis-associated aplastic anemia
Blood,
June 15, 2004;
103(12):
4588 - 4593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zeng, G. Chen, S. Kajigaya, O. Nunez, A. Charrow, E. M. Billings, and N. S. Young
Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers
Blood,
January 1, 2004;
103(1):
325 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Risitano, H. Kook, W. Zeng, G. Chen, N. S. Young, and J. P. Maciejewski
Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vbeta CDR3 spectratyping and flow cytometry
Blood,
June 17, 2002;
100(1):
178 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |